Dual Anti-HER2 Combination with Chemotherapy as First-line Treatment for HER2-positive Metastatic Breast Cancer
HER2-positive metastatic breast cancer is an aggressive subtype of breast cancer associated with poor prognosis due to high recurrence and mortality rates. The introduction of dual anti-HER2 therapy combined with chemotherapy has significantly improved treatment outcomes. A 50-year-old woman with...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Interna Publishing
2025-12-01
|
| coleção: | Acta Medica Indonesiana |
| Assuntos: | |
| Acesso em linha: | https://actamedindones.org/index.php/ijim/article/view/2971 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|